Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Percutaneous Coronary Intervention

Open-data reference.

13 US clinical trials · 3 currently recruiting

Active & Recent Trials

RECRUITING Phase 4 6,000 participants

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Duke University

NCT06909565

RECRUITING Phase 2 320 participants

Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial

Baystate Medical Center

NCT05925634

RECRUITING Phase 2 240 participants

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

VA Office of Research and Development

NCT04982419

ACTIVE NOT RECRUITING NA 1,924 participants

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

CathWorks

NCT05893498

ACTIVE NOT RECRUITING 1,643 participants

Precision PCI Registry

University of Florida

NCT06143709

ACTIVE NOT RECRUITING 99 participants

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions

Minneapolis Heart Institute Foundation

NCT05187351

COMPLETED 30,000 participants

The xDAPT External Validation Study

Icahn School of Medicine at Mount Sinai

NCT06736626

COMPLETED 19,000 participants

Patient Centered Machine Learning Model for Bleeding and Ischemic Risk

Abbott Medical Devices

NCT06089304

COMPLETED Phase 3 2,725 participants

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Boehringer Ingelheim

NCT02164864

COMPLETED NA 447 participants

Enhancing Cardiac Rehabilitation Through Behavioral Nudges

Denver Health and Hospital Authority

NCT03834155

COMPLETED 147 participants

Management of Antiplatelet Regimen During Surgical Procedures

Baylor Research Institute

NCT03981835

COMPLETED Phase 4 112 participants

Chewed Versus Integral Pill of Ticagrelor

Wake Forest University Health Sciences

NCT03708588

COMPLETED NA 48 participants

Exercise Prescription in Cardiac Rehabilitation

Baystate Medical Center

NCT03925493

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1
Phase 4 2

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Percutaneous Coronary Intervention Trial Landscape

ClinicalTrials.gov lists 13 US studies indexed under Percutaneous Coronary Intervention, and 3 of those are currently open to recruitment — roughly 23% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Percutaneous Coronary Intervention shows 3 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Percutaneous Coronary Intervention is led by Baystate Medical Center with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Percutaneous Coronary Intervention?

PlainTrial tracks 13 US clinical trials for Percutaneous Coronary Intervention, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Percutaneous Coronary Intervention?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →